Evidence map›Paper›PMID 42326476›Full record

ArticleCase reports in orthopedics2026

Renal Cell Carcinoma Metastasis to the Hamate Bone: A Case Report.

Abdullah Serin, Melih Oral, Mazlum Veysel Sili, Akin Uzumcugil, Baris Kafa, Nursah Tugtekin, Kemal Kosemehmetoglu, Mehmet Ayvaz

Abstract read
In one paragraph

Article in Case reports in orthopedics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Abdullah SerinDepartment of Orthopedics and Traumatology, Hacettepe University, Ankara, Türkiye, hacettepe.edu.tr.ORCID https://orcid.org/0000-0002-1438-5445
Melih OralIdil State Hospital, Idil, Türkiye.ORCID https://orcid.org/0000-0002-3800-9903
Mazlum Veysel SiliDepartment of Orthopedics and Traumatology, Hacettepe University, Ankara, Türkiye, hacettepe.edu.tr.ORCID https://orcid.org/0009-0006-9237-2160
Akin UzumcugilDivision of Hand Surgery, Department of Orthopedics and Traumatology, Hacettepe University, Ankara, Türkiye, hacettepe.edu.tr.ORCID https://orcid.org/0000-0002-1468-3039
Baris KafaDivision of Hand Surgery, Department of Orthopedics and Traumatology, Hacettepe University, Ankara, Türkiye, hacettepe.edu.tr.ORCID https://orcid.org/0000-0003-4548-534X
Nursah TugtekinDepartment of Pathology, Hacettepe University, Ankara, Türkiye, hacettepe.edu.tr.ORCID https://orcid.org/0009-0001-4800-9851
Kemal KosemehmetogluDepartment of Pathology, Hacettepe University, Ankara, Türkiye, hacettepe.edu.tr.ORCID https://orcid.org/0000-0002-7747-0460
Mehmet AyvazDepartment of Orthopedics and Traumatology, Hacettepe University, Ankara, Türkiye, hacettepe.edu.tr.ORCID https://orcid.org/0000-0002-6471-127X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Renal cell carcinoma (RCC) rarely metastasizes to the carpal bones. We describe a 43-year-old woman with a history of RCC who presented with ulnar-sided wrist pain. Imaging demonstrated complete osteolytic destruction of the hamate. Treatment consisted of excision of the hamate, intralesional curettage, cement reconstruction, and internal fixation to the adjacent carpal bones and the fourth and fifth metacarpals. At 15 months of follow-up, no local recurrence, carpal instability, or implant-related complications were observed. Surgical excision with cementation and internal fixation achieved local tumor control, maintained carpal stability, and enabled early functional recovery in this rare case of hamate metastasis from RCC.

Indexed as

curettage and cementationhamate boneinternal fixationosteolytic lesionrenal cell carcinoma

Identifiers

PMID42326476
PMCPMC13282455

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.